Skip to main content

Table 1 Patient demographics

From: Predicting clinical outcomes in chordoma patients receiving immunotherapy: a comparison between volumetric segmentation and RECIST

Age range (median)

32–82 (60)

Gender

# (%)

 Male

18 (85.7)

 Female

3 (14.3)

Prior treatment

# (%)

 Surgery

20 (95.2)

 Radiation

20 (95.2)

Primary tumor

# (%)

 Lumbar/sacral spine

14 (66.7)

 Clivus

6 (28.6)

 Cervical spine

1 (4.8)

Metastatic disease at baseline

# (%)

 Yes

14 (66.7)

 No

7 (33.3)